Menu
Back to Journals » Journal of Pain Research » Oral Methylnaltrexone in the treatment of patients with opioid-induced constipation and noncancer pain
SJR OA
CiteScore
Impact Factor
Journal of Pain Research
ISSN: 1178-7090
- View all (3067)
- Volume 17, 2024 (144)
- Volume 16, 2023 (350)
- Volume 15, 2022 (331)
- Volume 14, 2021 (356)
- Volume 13, 2020 (359)
- Volume 12, 2019 (330)
- Volume 11, 2018 (336)
- Volume 10, 2017 (309)
- Volume 9, 2016 (140)
- Volume 8, 2015 (93)
- Volume 7, 2014 (76)
- Volume 6, 2013 (88)
- Volume 5, 2012 (63)
- Volume 4, 2011 (44)
- Volume 3, 2010 (26)
- Volume 2, 2009 (15)
- Volume 1, 2008 (7)
Journal Articles:
- Pain in Space: a Journey of Discovery (2)
- Complex Regional Pain Syndrome (7)
- Cancer Pain (8)
- The Future of Pain Medicine: Emerging Technologies, Treatments, and Education (1)
- Childbirth and Postpartum Pain: The Importance of Maternal Pain Control Beyond the Birth Experience (9)
- Orofacial Pain: A new US Dental Specialty. Where are we now? (2)
- Dysmenorrhea: Therapy and Mechanism (3)
- Cannabis as pain medicine - the dark vs. the light side of a newly discovered treatment (1)
- Methylnaltrexone for Opioid-Induced Constipation (2)
- Tapentadol for moderate to severe acute pain in children and adolescents (11)
- Inhaled methoxyflurane for the treatment of acute trauma pain (4)
- Tapentadol: just another opioid or an innovative strong analgesic? (8)
- From acute to chronic pain: bench to bedside findings from consortium of SIMPAR young researchers (4)
- Oral Methylnaltrexone in the treatment of patients with opioid-induced constipation and noncancer pain (2)
Oral Methylnaltrexone in the treatment of patients with opioid-induced constipation and noncancer pain
In these linked studies, Webster and Israel evaluate the safety and efficacy of oral methylnaltrexone for opioid-induced constipation (OIC), concluding that oral methylnaltrexone does not elicit opioid withdrawal or interfere with opioid analgesia and is efficacious and safe for the treatment of OIC.
Original Research
Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain
Webster LR, Israel RJ
Journal of Pain Research 2018, 11:1503-1510
Published Date: 13 August 2018
Original Research
Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
Webster LR, Israel RJ
Journal of Pain Research 2018, 11:2509-2516
Published Date: 23 October 2018